Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Targeted Anticancer Therapies Congress 2022

07 - 08 Mar 2022

Virtual

ESMO-TAT-2022-1000x1000-No-Bubbles

Abstracts and ePosters are open access.

Presentations (slides) and webcasts are available to registered delegates and ESMO members.

The ESMO Targeted Anticancer Therapies Congress 2022, is the premier international meeting focusing on promising new anticancer targets and agents, with a particular focus on those in early phase clinical development. 

All resources are published

Use the search box below to type any keywords, or the abstract number

Watch the webcasts from our industry partner Satellite Symposia:
Daiichi Sankyo/AstraZeneca - From bench to bedside and back to bench: The evolution of antibody–drug conjugates in the treatment of cancer

ESMO thanks the authors for their generosity.
The use of these presentations is for personal educational purposes only.

Hide
Filter by:

There are 119 resources available

Live Q&A and discussion

Presenter: Timothy Yap

Session: Patient selection for synthetic lethality trials

Resources:

Webcast

Live TAT 2022 highlights

Presenter: Anastasios Stathis

Session: Take home messages and close

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.